Drug developer rattles tin for another cash dollop
MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on the ASX,… read more
Tanarra urges Healius to halt imaging business sale
PERTH: John Wylie’s Tanarra Capital has urged Healius, the pathology giant where it is one… read more
Health boss censured over blatant electioneering in newsletter
BRISBANE: A Queensland Health executive has been reminded of the importance of being impartial after… read more
Private equity eyes Ramsay Health Care as attractive target
SYDNEY: There’s an increasing amount of talk again about a deal involving Ramsay Health Care,… read more
